Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...
EQS-Adhoc: Merck KGaA: Merck KGaA confirms discussions with Springworks Therapeutics, Inc. on potential acquisition ...
Darmstadt. Der Darmstädter Pharmaziekonzern Merck KGaA bestätigt fortgeschrittene Gespräche mit Springworks Therapeutics, Inc. Das Darmstädter Unternehmen reagierte am späten Montagabend ...
Big Tech and pharmaceutical companies are accelerating the implementation of artificial intelligence in the healthcare ...
TD Cowen downgraded Merck (MRK) to Hold from Buy with a price target of $100, down from $121. The firm says its Buy thesis “broke down” with Gardasil’s challenges in China. It is ...
Der Negativlauf des SV Darmstadt 98 in der 2. Fußball-Bundesliga geht weiter. Auch im fünften Spiel nacheinander gelang den ...
Merck KGaA, the German healthcare and technology group, is in advanced talks to acquire U.S. cancer and rare diseases ...
New York/Frankfurt (Reuters) - Der Darmstädter Pharma- und Technologiekonzern Merck KGaA hat ein Auge auf den ...
Stamford-based SpringWorks Therapeutics, a commercial-stage biotech company developing treatments for rare diseases and ...
In der Saison 2016/2017 verzichtete Merck auf sein erworbenes Namensrecht, um das Lebenswerk von Jonathan Heimes zu würdigen und die gemeinnützige Gesellschaft "DUMUSSTKÄMPFEN" zugunsten ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback